Aspire Biopharma Holdings (ASBP) Change in Inventory (2025 - 2026)

Aspire Biopharma Holdings' (ASBP) quarterly Change in Inventory came in at $116814.0 in Q1 2026, down 46.35% on a QoQ basis from $217723.0 in Q4 2025.

Aspire Biopharma Holdings (ASBP) Change in Inventory (2025 - 2026) Analysis & Trends

Aspire Biopharma Holdings (ASBP) has 2 years of Change in Inventory data on file, last reported at $116814.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 71.84 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Aspire Biopharma Holdings 1.09 Mn -733,865.14 5,750.00 116,814.00

Historic Data

Download Data
DateValue
Mar 31, 2026 116,814.00
Mar 31, 2026 116,814.00
Dec 31, 2025 217,723.00
Dec 31, 2025 217,723.00